Cytosorbents Corporation (CTSO): Price and Financial Metrics

CTSO POWR Grades

• Growth is the dimension where CTSO ranks best; there it ranks ahead of 88.67% of US stocks.
• The strongest trend for CTSO is in Growth, which has been heading up over the past 177 days.
• CTSO's current lowest rank is in the Momentum metric (where it is better than 9.23% of US stocks).

CTSO Stock Summary

• With a market capitalization of $56,436,906, CYTOSORBENTS CORP has a greater market value than only 17.39% of US stocks.
• With a year-over-year growth in debt of 37.78%, CYTOSORBENTS CORP's debt growth rate surpasses 84.02% of about US stocks.
• The volatility of CYTOSORBENTS CORP's share price is greater than that of 80.96% US stocks with at least 200 days of trading history.
• Stocks with similar financial metrics, market capitalization, and price volatility to CYTOSORBENTS CORP are AMST, DDD, STRM, AIRG, and AQST.
• CTSO's SEC filings can be seen here. And to visit CYTOSORBENTS CORP's official web site, go to www.cytosorbents.com.

CTSO Valuation Summary

• In comparison to the median Healthcare stock, CTSO's price/sales ratio is 52.78% lower, now standing at 1.7.
• CTSO's price/earnings ratio has moved down 1.1 over the prior 193 months.

Below are key valuation metrics over time for CTSO.

CTSO Growth Metrics

Its 4 year net income to common stockholders growth rate is now at -55.35%.
• The 3 year net income to common stockholders growth rate now stands at -53.6%.
• Its 2 year net income to common stockholders growth rate is now at -64.61%.

CTSO's revenue has moved up $25,249,351 over the prior 67 months.

The table below shows CTSO's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	36.08053	-28.38555	-41.35347
2022-06-30	37.72959	-25.78428	-35.55892
2022-03-31	41.2581	-19.78053	-29.35722
2021-12-31	43.16553	-14.0056	-24.55865
2021-09-30	44.33911	-9.571806	-15.92936
2021-06-30	45.1253	-8.722604	-10.3628

CTSO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• CTSO has a Quality Grade of D, ranking ahead of 21.38% of graded US stocks.
• CTSO's asset turnover comes in at 0.475 -- ranking 101st of 186 Medical Equipment stocks.
• NVCR, CUTR, and HAE are the stocks whose asset turnover ratios are most correlated with CTSO.

The table below shows CTSO's key quality metrics over time.